European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Baqsimi, glucagon, Date of authorisation: 16/12/2019, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 15 September 2025 - 16:27

Human medicines European public assessment report (EPAR): Baqsimi, glucagon, Date of authorisation: 16/12/2019, Revision: 6, Status: Authorised

Committee for Advanced Therapies (CAT) workshop on gene editing, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 September 2025, 10:00 (CEST) to 16 September 2025, 17:00 (CEST)

Submitted by Anonymous (not verified) on 15 September 2025 - 16:08

Committee for Advanced Therapies (CAT) workshop on gene editing, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 September 2025, 10:00 (CEST) to 16 September 2025, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Emselex, darifenacin hydrobromide, Date of authorisation: 22/10/2004, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 15 September 2025 - 16:02

Human medicines European public assessment report (EPAR): Emselex, darifenacin hydrobromide, Date of authorisation: 22/10/2004, Revision: 28, Status: Authorised

Committee for Medicinal Products for Human Use (CHMP): 15-18 September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 15 September 2025 to 18 September 2025

Submitted by Anonymous (not verified) on 15 September 2025 - 15:20

Committee for Medicinal Products for Human Use (CHMP): 15-18 September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 15 September 2025 to 18 September 2025

Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases

Submitted by Anonymous (not verified) on 15 September 2025 - 14:23

Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 22, Status: Authorised

Submitted by Anonymous (not verified) on 15 September 2025 - 13:56

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 22, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness